XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings (Accumulated Deficit)
Common stock, beginning balance (in shares) at May. 27, 2023   35,545        
Beginning balance at May. 27, 2023 $ 414,520 $ 355 $ 378,657 $ (34,850) $ (17,290) $ 87,648
Treasury stock, beginning balance (in shares) at May. 27, 2023       2,070    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   32        
Exercise of stock options 452 $ 1 451      
Stock-based compensation expense 4,075   4,075      
Issuance of common stock purchased under Employee Stock Purchase Plan (in shares)   456        
Issuance of common stock purchased under Employee Stock Purchase Plan 5,651 $ 5 5,646      
Issuance of restricted stock (in shares)   75   38    
Issuance of restricted stock 0 $ 1 (1) $ 648   (648)
Issuance of common stock upon vesting of equity awards, net of shares withheld to cover taxes (in shares)   86        
Issuance of common stock upon vesting of equity awards, net of shares withheld to cover taxes (1,335) $ 1 (1,336)      
Cash dividends declared ($0.42 per share) (14,144)         (14,144)
Dividend equivalents on equity awards 0   441     (441)
Repurchase of common stock (in shares)       354    
Repurchase of common stock (5,000)     $ (5,000)    
Currency translation adjustment 79       79  
Net (loss) income 10,562         10,562
Common stock, ending balance (in shares) at Feb. 24, 2024   36,194        
Ending balance at Feb. 24, 2024 414,860 $ 363 387,933 $ (39,202) (17,211) 82,977
Treasury stock, ending balance (in shares) at Feb. 24, 2024       2,386    
Common stock, beginning balance (in shares) at Nov. 25, 2023   35,929        
Beginning balance at Nov. 25, 2023 413,604 $ 360 383,662 $ (39,811) (16,533) 85,926
Treasury stock, beginning balance (in shares) at Nov. 25, 2023       2,422    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   6        
Exercise of stock options 68   68      
Stock-based compensation expense 1,177   1,177      
Issuance of common stock purchased under Employee Stock Purchase Plan (in shares)   258        
Issuance of common stock purchased under Employee Stock Purchase Plan 2,877 $ 3 2,874      
Issuance of restricted stock (in shares)       36    
Issuance of restricted stock 0     $ 609   (609)
Issuance of common stock upon vesting of equity awards, net of shares withheld to cover taxes (in shares)   1        
Issuance of common stock upon vesting of equity awards, net of shares withheld to cover taxes (6)   (6)      
Cash dividends declared ($0.42 per share) (4,732)         (4,732)
Dividend equivalents on equity awards 0   158     (158)
Currency translation adjustment (678)       (678)  
Net (loss) income 2,550         2,550
Common stock, ending balance (in shares) at Feb. 24, 2024   36,194        
Ending balance at Feb. 24, 2024 $ 414,860 $ 363 387,933 $ (39,202) (17,211) 82,977
Treasury stock, ending balance (in shares) at Feb. 24, 2024       2,386    
Common stock, beginning balance (in shares) at May. 25, 2024 33,556 36,194        
Beginning balance at May. 25, 2024 $ 418,763 $ 363 389,720 $ (42,202) (17,713) 88,595
Treasury stock, beginning balance (in shares) at May. 25, 2024 2,638     2,638    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 0          
Stock-based compensation expense $ 5,657   5,657      
Issuance of common stock purchased under Employee Stock Purchase Plan (in shares)   493        
Issuance of common stock purchased under Employee Stock Purchase Plan 3,914 $ 4 3,910      
Issuance of restricted stock (in shares)   80   (69)    
Issuance of restricted stock 0 $ 1 (1) $ 1,170   (1,170)
Issuance of common stock upon vesting of equity awards, net of shares withheld to cover taxes (in shares)   254        
Issuance of common stock upon vesting of equity awards, net of shares withheld to cover taxes (1,622) $ 2 (1,624)      
Cash dividends declared ($0.42 per share) (13,951)         (13,951)
Dividend equivalents on equity awards 0   891     (891)
Repurchase of common stock (in shares)       1,383    
Repurchase of common stock (13,014)     $ (13,014)    
Currency translation adjustment (3,447)       (3,447)  
Net (loss) income $ (118,474)         (118,474)
Common stock, ending balance (in shares) at Feb. 22, 2025 33,069 37,021        
Ending balance at Feb. 22, 2025 $ 277,826 $ 370 398,553 $ (54,046) (21,160) (45,891)
Treasury stock, ending balance (in shares) at Feb. 22, 2025 3,952     3,952    
Common stock, beginning balance (in shares) at Nov. 23, 2024   36,757        
Beginning balance at Nov. 23, 2024 $ 325,677 $ 368 394,544 $ (52,204) (21,176) 4,145
Treasury stock, beginning balance (in shares) at Nov. 23, 2024       3,666    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 1,960   1,960      
Issuance of common stock purchased under Employee Stock Purchase Plan (in shares)   264        
Issuance of common stock purchased under Employee Stock Purchase Plan 1,904 $ 2 1,902      
Issuance of restricted stock (in shares)       (69)    
Issuance of restricted stock 0     $ 1,170   (1,170)
Issuance of common stock upon vesting of equity awards, net of shares withheld to cover taxes (36)   (36)      
Cash dividends declared ($0.42 per share) (4,631)         (4,631)
Dividend equivalents on equity awards 0   183     (183)
Repurchase of common stock (in shares)       355    
Repurchase of common stock (3,012)     $ (3,012)    
Currency translation adjustment 16       16  
Net (loss) income $ (44,052)         (44,052)
Common stock, ending balance (in shares) at Feb. 22, 2025 33,069 37,021        
Ending balance at Feb. 22, 2025 $ 277,826 $ 370 $ 398,553 $ (54,046) $ (21,160) $ (45,891)
Treasury stock, ending balance (in shares) at Feb. 22, 2025 3,952     3,952